Trials / Sponsors / Jeffrey Clarke
Jeffrey Clarke
Academic / Other · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Study of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer Non Small Cell Lung Cancer, Metastatic NSCLC, Recurrent Non Small Cell Lung Cancer | Phase 2 | 2023-02-17 |
| Terminated | Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Small-cell Lung Cancer, Brain Metastases | Phase 2 | 2021-01-05 |
| Completed | Phase II Clinical Trial of NIVO-IPI-TAXANE in Untreated Metastatic NSCLC Non-small Cell Lung Cancer | Phase 2 | 2018-10-02 |
| Completed | A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer - QUILT-3.007 Advanced Solid Tumors, Non-small Cell Lung Cancer | Phase 1 | 2010-04-01 |